Interleukin-6 as a therapeutic target in human ovarian cancer

More about Open Access at the Crick

Abstract

We investigated whether inhibition of interleukin 6 (IL-6) has therapeutic activity in ovarian cancer via abrogation of a tumor-promoting cytokine network.

Journal details

Volume 17
Issue number 18
Pages 6083-6096
Publication date

Keywords